234 related articles for article (PubMed ID: 24647400)
41. Wild poliovirus type 1 and type 3 importations--15 countries, Africa, 2008-2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(14):357-62. PubMed ID: 19373195
[TBL] [Abstract][Full Text] [Related]
42. Assessing the risks for poliovirus outbreaks in polio-free countries--Africa, 2012-2013.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Sep; 62(37):768-72. PubMed ID: 24048153
[TBL] [Abstract][Full Text] [Related]
43. Review of use of inactivated poliovirus vaccine in campaigns to control type 2 circulating vaccine derived poliovirus (cVDPV) outbreaks.
Estivariz CF; Kovacs SD; Mach O
Vaccine; 2023 Apr; 41 Suppl 1(Suppl 1):A113-A121. PubMed ID: 35365341
[TBL] [Abstract][Full Text] [Related]
44. Update on vaccine-derived polioviruses - worldwide, July 2012-December 2013.
Diop OM; Burns CC; Wassilak SG; Kew OM;
MMWR Morb Mortal Wkly Rep; 2014 Mar; 63(11):242-8. PubMed ID: 24647401
[TBL] [Abstract][Full Text] [Related]
45. Cost analysis of post-polio certification immunization policies.
Sangrujee N; Cáceres VM; Cochi SL
Bull World Health Organ; 2004 Jan; 82(1):9-15. PubMed ID: 15106295
[TBL] [Abstract][Full Text] [Related]
46. [Polio vaccines, eradication and posterradication].
Salmerón García F; Portela Moreira A; Soler Soneira M; López Hernández S; Chamorro Somoza Díaz-Sarmiento M; Pérez González I; Rubio Gómez MI; Pérez González A; Sagredo Rodríguez A; Ruiz Antúnez S; Timón Jiménez M; Frutos Cabanillas G
Rev Esp Salud Publica; 2013; 87(5):497-505. PubMed ID: 24322286
[TBL] [Abstract][Full Text] [Related]
47. Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine.
Hotta C; Ogawa T; Shirasawa H
Hum Vaccin Immunother; 2019; 15(5):1154-1159. PubMed ID: 30676843
[TBL] [Abstract][Full Text] [Related]
48. Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.
Duintjer Tebbens RJ; Hampton LM; Thompson KM
BMC Infect Dis; 2016 Jun; 16():237. PubMed ID: 27246198
[TBL] [Abstract][Full Text] [Related]
49. Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis.
Swartz TA; Handsher R; Manor Y; Stoeckel P; Barkay A; Mendelson E; Leventhal A
Vaccine; 1998 Dec; 16(20):2090-5. PubMed ID: 9796069
[TBL] [Abstract][Full Text] [Related]
50. Progress toward poliomyelitis eradication--Pakistan and Afghanistan, 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Mar; 57(12):315-9. PubMed ID: 18368007
[TBL] [Abstract][Full Text] [Related]
51. Progress toward polio eradication--Somalia, 1998-2013.
Mbaeyi C; Kamadjeu R; Mahamud A; Webeck J; Ehrhardt D; Mulugeta A
J Infect Dis; 2014 Nov; 210 Suppl 1(0 1):S173-80. PubMed ID: 25316833
[TBL] [Abstract][Full Text] [Related]
52. Progress toward interruption of wild poliovirus transmission--worldwide, January 2007-April 2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 May; 57(18):489-94. PubMed ID: 18463607
[TBL] [Abstract][Full Text] [Related]
53. Progress Toward Poliomyelitis Eradication - Pakistan, January 2020-July 2021.
Mbaeyi C; Baig S; Khan Z; Young H; Kader M; Jorba J; Safdar MR; Jafari H; Franka R
MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(39):1359-1364. PubMed ID: 34591827
[TBL] [Abstract][Full Text] [Related]
54. Progress toward interruption of wild poliovirus transmission--worldwide, January 2006-May 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Jul; 56(27):682-5. PubMed ID: 17625496
[TBL] [Abstract][Full Text] [Related]
55. Eradication of poliomyelitis in the United States.
Nathanson N
Rev Infect Dis; 1982; 4(5):940-50. PubMed ID: 7146731
[TBL] [Abstract][Full Text] [Related]
56. Progress toward poliomyelitis eradication - Afghanistan and Pakistan, January 2011-August 2012.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Oct; 61(39):790-5. PubMed ID: 23034587
[TBL] [Abstract][Full Text] [Related]
57. Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunization.
Khan MM; Sharma S; Tripathi B; Alvarez FP
Public Health; 2017 Jan; 142():31-38. PubMed ID: 28057194
[TBL] [Abstract][Full Text] [Related]
58. [End phase challenges of poliomyelitis eradication programme realization].
Jarzabek Z
Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
[TBL] [Abstract][Full Text] [Related]
59. Global Polio Eradication Initiative Strategic Plan, 2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Feb; 53(5):107-8. PubMed ID: 14961005
[TBL] [Abstract][Full Text] [Related]
60. Update on Wild Poliovirus Type 1 Outbreak - Southeastern Africa, 2021-2022.
Davlantes E; Greene SA; Tobolowsky FA; Biya O; Wiesen E; Abebe F; Weldetsadik MB; Eboh VA; Chisema MN; da Conceição Mário B; Tinuga F; Bobo PM; Chigodo CK; Sethy G; Hellström JM; Goundara AM; Burny ME; Mwale JC; Jorba J; Makua KS; Howard W; Seakamela L; Okiror S; Thompson A; Ali A; Samba D; Agbo C; Kabamba L; Kazoka A; Zomahoun DL; Manneh F; Abdelrahim K; Kamugisha C; Umar AS
MMWR Morb Mortal Wkly Rep; 2023 Apr; 72(15):391-397. PubMed ID: 37053125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
